Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005)

Jae Kwan Lee, S. H. Song, I. Kim, K. H. Lee, B. G. Kim, J. W. Kim, Y. T. Kim, S. Y. Park, M. S. Cha, S. B. Kang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The purpose of this study is to assess clinicopathologic features of pseudomyxoma peritonei (PMP) that has ovarian pathology and its relationship with the prognosis. From 1995 to 2004, the clinical records and follow-up data of 35 patients with PMP, which had primarily originated from the ovary, were collected from 11 institutes of gynecologic oncology in Korea and retrospectively analyzed. All patients had ovarian lesion histologically confirmed with PMP. The mean age at diagnosis was 53.7 years (range: 16-82 years). There were 25 (71.4%) patients with disseminated peritoneal adenomucinosis, 5 (14.3%) with peritoneal mucinous carcinomatosis with intermediate group, and 5 (14.3%) with peritoneal mucinous carcinomatosis. The clinical stages at diagnosis were IA in 2 patients, IIIB in 4, IIIC in 23, IV in 1, and unknown in 5. In preoperative tumor markers, the positive rates were 72% (CA125), 47.4% (CA19-9), and 84.6% (CEA). Thirty-four patients underwent surgical staging or cytoreduction, and then 27 patients (77%) received adjuvant chemotherapy that was given to patients in a nonuniform fashion. The 5-year survival for 35 patients was 87%. Survival rate was significantly lower in patients >50 years of age (P = 0.002). Our data showed that age of the patient is the only significant prognostic factor in PMP that has ovarian lesion.

Original languageEnglish
Pages (from-to)916-920
Number of pages5
JournalInternational Journal of Gynecological Cancer
Volume18
Issue number5
DOIs
Publication statusPublished - 2008 Sep 1

Fingerprint

Pseudomyxoma Peritonei
Multicenter Studies
Retrospective Studies
Neoplasms
Carcinoma
Adjuvant Chemotherapy
Korea
Tumor Biomarkers
Ovary
Survival Rate

Keywords

  • Pseudomyxoma peritonei
  • Survival

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology
  • Cancer Research

Cite this

Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005). / Lee, Jae Kwan; Song, S. H.; Kim, I.; Lee, K. H.; Kim, B. G.; Kim, J. W.; Kim, Y. T.; Park, S. Y.; Cha, M. S.; Kang, S. B.

In: International Journal of Gynecological Cancer, Vol. 18, No. 5, 01.09.2008, p. 916-920.

Research output: Contribution to journalArticle

Lee, Jae Kwan ; Song, S. H. ; Kim, I. ; Lee, K. H. ; Kim, B. G. ; Kim, J. W. ; Kim, Y. T. ; Park, S. Y. ; Cha, M. S. ; Kang, S. B. / Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005). In: International Journal of Gynecological Cancer. 2008 ; Vol. 18, No. 5. pp. 916-920.
@article{d034c356cb204fb5a1402fa58e955890,
title = "Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005)",
abstract = "The purpose of this study is to assess clinicopathologic features of pseudomyxoma peritonei (PMP) that has ovarian pathology and its relationship with the prognosis. From 1995 to 2004, the clinical records and follow-up data of 35 patients with PMP, which had primarily originated from the ovary, were collected from 11 institutes of gynecologic oncology in Korea and retrospectively analyzed. All patients had ovarian lesion histologically confirmed with PMP. The mean age at diagnosis was 53.7 years (range: 16-82 years). There were 25 (71.4{\%}) patients with disseminated peritoneal adenomucinosis, 5 (14.3{\%}) with peritoneal mucinous carcinomatosis with intermediate group, and 5 (14.3{\%}) with peritoneal mucinous carcinomatosis. The clinical stages at diagnosis were IA in 2 patients, IIIB in 4, IIIC in 23, IV in 1, and unknown in 5. In preoperative tumor markers, the positive rates were 72{\%} (CA125), 47.4{\%} (CA19-9), and 84.6{\%} (CEA). Thirty-four patients underwent surgical staging or cytoreduction, and then 27 patients (77{\%}) received adjuvant chemotherapy that was given to patients in a nonuniform fashion. The 5-year survival for 35 patients was 87{\%}. Survival rate was significantly lower in patients >50 years of age (P = 0.002). Our data showed that age of the patient is the only significant prognostic factor in PMP that has ovarian lesion.",
keywords = "Pseudomyxoma peritonei, Survival",
author = "Lee, {Jae Kwan} and Song, {S. H.} and I. Kim and Lee, {K. H.} and Kim, {B. G.} and Kim, {J. W.} and Kim, {Y. T.} and Park, {S. Y.} and Cha, {M. S.} and Kang, {S. B.}",
year = "2008",
month = "9",
day = "1",
doi = "10.1111/j.1525-1438.2007.01146.x",
language = "English",
volume = "18",
pages = "916--920",
journal = "International journal of gynecological cancer : official journal of the International Gynecological Cancer Society",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Retrospective multicenter study of a clinicopathologic analysis of pseudomyxoma peritonei associated with ovarian tumors (KGOG 3005)

AU - Lee, Jae Kwan

AU - Song, S. H.

AU - Kim, I.

AU - Lee, K. H.

AU - Kim, B. G.

AU - Kim, J. W.

AU - Kim, Y. T.

AU - Park, S. Y.

AU - Cha, M. S.

AU - Kang, S. B.

PY - 2008/9/1

Y1 - 2008/9/1

N2 - The purpose of this study is to assess clinicopathologic features of pseudomyxoma peritonei (PMP) that has ovarian pathology and its relationship with the prognosis. From 1995 to 2004, the clinical records and follow-up data of 35 patients with PMP, which had primarily originated from the ovary, were collected from 11 institutes of gynecologic oncology in Korea and retrospectively analyzed. All patients had ovarian lesion histologically confirmed with PMP. The mean age at diagnosis was 53.7 years (range: 16-82 years). There were 25 (71.4%) patients with disseminated peritoneal adenomucinosis, 5 (14.3%) with peritoneal mucinous carcinomatosis with intermediate group, and 5 (14.3%) with peritoneal mucinous carcinomatosis. The clinical stages at diagnosis were IA in 2 patients, IIIB in 4, IIIC in 23, IV in 1, and unknown in 5. In preoperative tumor markers, the positive rates were 72% (CA125), 47.4% (CA19-9), and 84.6% (CEA). Thirty-four patients underwent surgical staging or cytoreduction, and then 27 patients (77%) received adjuvant chemotherapy that was given to patients in a nonuniform fashion. The 5-year survival for 35 patients was 87%. Survival rate was significantly lower in patients >50 years of age (P = 0.002). Our data showed that age of the patient is the only significant prognostic factor in PMP that has ovarian lesion.

AB - The purpose of this study is to assess clinicopathologic features of pseudomyxoma peritonei (PMP) that has ovarian pathology and its relationship with the prognosis. From 1995 to 2004, the clinical records and follow-up data of 35 patients with PMP, which had primarily originated from the ovary, were collected from 11 institutes of gynecologic oncology in Korea and retrospectively analyzed. All patients had ovarian lesion histologically confirmed with PMP. The mean age at diagnosis was 53.7 years (range: 16-82 years). There were 25 (71.4%) patients with disseminated peritoneal adenomucinosis, 5 (14.3%) with peritoneal mucinous carcinomatosis with intermediate group, and 5 (14.3%) with peritoneal mucinous carcinomatosis. The clinical stages at diagnosis were IA in 2 patients, IIIB in 4, IIIC in 23, IV in 1, and unknown in 5. In preoperative tumor markers, the positive rates were 72% (CA125), 47.4% (CA19-9), and 84.6% (CEA). Thirty-four patients underwent surgical staging or cytoreduction, and then 27 patients (77%) received adjuvant chemotherapy that was given to patients in a nonuniform fashion. The 5-year survival for 35 patients was 87%. Survival rate was significantly lower in patients >50 years of age (P = 0.002). Our data showed that age of the patient is the only significant prognostic factor in PMP that has ovarian lesion.

KW - Pseudomyxoma peritonei

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=51749088587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51749088587&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1438.2007.01146.x

DO - 10.1111/j.1525-1438.2007.01146.x

M3 - Article

C2 - 18248391

AN - SCOPUS:51749088587

VL - 18

SP - 916

EP - 920

JO - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

JF - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

SN - 1048-891X

IS - 5

ER -